Nutra Pharma Corp (NPHC)

[Goofy R]

RIK LIED 10 YEARS AGO ABOUT PRODUCT-BEING-IN-WALGREENS!!FAKE-PRODUCT!LYING-POS-CEO!!

EVERYTHING RIK DOES IS A LIE!!

FAKE PRODUCT DOESN'T WORK -- I TRIED IT!! IT'S A FAKE PRODUCT!!!

RIK AND NPHC ARE FINISHED!!

THE SEC WILL SHUT DOWN THIS COMPANY AND BAN RIK FROM EVER BEING INVOLVED IN ANOTHER PUBLIC COMPANY AGAIN!! HE COULD VERY WELL FIND HIMSELF IN JAIL IF THE SEC PASSES ON THE CASE TO THE DOJ!!!!

SEC LAWSUIT IS A 43 PAGE DOCUMENT FILLED WITH ABSOLUTE AND INDESPUTABLE TRUTHS OF FRAUD, MISLEADING PRs, AND STOCK MANIPULATION!!

RIK IS DONE!!! SO IS NPHC!!!

ZERO REVENUES!!!

ZERO EARNINGS!!!

MASSIVE DEBT!!!

MASSIVE LOSSES!!!

HERE IS THE SEC LAWSUIT:

https://www.sec.gov/litigation/complaints/2018/comp24295.pdf

RIK'S CRIMINAL FRIENDS:

Phil Piccolo:

http://worldwidescam.com/sumphil.htm

http://patrickpretty.com/2014/04/27/mlm-watchdog-phil-piccolo-is-scamming-again/

SEAN PETER McMANUS:

https://structuredsettlements.typepad.com/structured_settlements_4r/2019/01/patriot-settlement-resources-mcmanus-sued-by-finra-for-selling-snake-oil-without-a-license.html

Waiora Lawsuit against Rik (Fake Ingredients/Fraud):

http://aprilmarietucker.com/wp-content/uploads/2013/05/Stanley-J.-Cherelstein-Waiora-lawsuit.pdf

https://www.law360.com/articles/922469/health-co-barred-from-selling-supplement-in-ip-row

Tommy Edward Crutchfield (Snake Guy in the video):

https://www.justice.gov/archive/opa/pr/1999/April/140enr.htm

Dr. Keith Gordon, DMV (Pet Pain Away Spokesperson):

https://www.mycentraljersey.com/story/news/local/middlesex-county/2015/12/28/fancy-pups-avenel-closed-owner-arrested/77981976/

COMPLAINT FOR PATENT INFRINGEMENT, BREACH OF LICENSE AGREEMENT, FRAUD AND RELATED CLAIMS (JURY DEMAND ENDORSED HEREON):

https://insight.rpxcorp.com/litigation_documents/2326309

Excerpt:

Rik’s FRAUD!!!:

22. Although Deitsch and NDA arranged to begin manufacture and sale of Product, they refused to inform Plaintiff, on later inquiries, of any manufacturing details, including the identity of the manufacturer. Case: 5:07-cv-00785-JG Doc #: 1 Filed: 03/16/07 8 of 16. PageID #: 62
-9-23.
Shortly after entering into the Agreement, NDA claimed to encounter problems with its marketing efforts in Germany. In a June 30, 2004, e-mail from his “nutrapharma” e-mail address, Deitsch informed Plaintiff of problems with “the German group” and the manufacturing of the Product.
Plaintiff now believes that no “German Division of MRI Labs” was available to NDA and that Deitsch misrepresented his German marketing infrastructure to induce Plaintiff to enter into the Agreement.



NUTRA PHARMA CORP.
Consolidated Statements of Operations


For the Years Ended
December 31,
2017 2016
Net sales $ 120,979 168,356
Cost of sales 26,903 38,965
Impairment of inventory - 184,039
Gross profit 94,076 (54,648)

Operating expenses:
Selling, general and administrative - including stock based compensation of $73,576 and $390,608 for the years ended December 31, 2017 and 2016, respectively 1,476,016 1,988,868
Total operating expenses 1,476,016 1,988,868
Loss from operations (1,381,940) (2,043,516)

Other (income) expenses
Rental income - 19,381
Interest expense (358,651) (293,785)
Change in fair value of derivatives (2,273,968) (1,258,649)
Gain (Loss) on settlement of indebtedness, net (14,189) 128,956
Other expenses (2,646,808) (1,404,097)
Net loss before income taxes (4,028,748) (3,447,613)
Provision for income taxes - -
Net loss $ (4,028,748) (3,447,613)